GlassScriptPhysician profile
Ralph George Menard, JR.
NPI 1407876014
$5,732.70
in general payments reported to CMS, 2019-2025
28 companies · $1,079 in 2025
The $1,079 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,556 · 2020: $413 · 2021: $462 · 2022: $382 · 2023: $710 · 2024: $1,131 · 2025: $1,079.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,764 · Travel and Lodging: $128 · Education: $28.65.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,763.85 |
| Travel and Lodging | $127.53 |
| Education | $28.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,673.73 | 2019-2025 | Wavewriter Alpha Prime 16, Intracept, General - Pain Management |
| Nevro Corp. | $733.13 | 2023-2024 | Senza |
| Medtronic, INC. | $569.74 | 2021-2025 | Kyphon Express II Kyphopak Tray, Osteocool Rf Ablation System |
| Vertiflex, INC. | $421.48 | 2019 | |
| Globus Medical, INC. | $364.87 | 2025 | Senza, Vyrsa V1, Omnia |
| Pacira Pharmaceuticals Incorporated | $306.16 | 2024-2025 | Iovera, Zilretta |
| Saluda Medical Americas, INC. | $214.96 | 2024-2025 | Evoke |
| Abbvie INC. | $209.63 | 2019-2025 | |
| Amgen INC. | $206.95 | 2019-2025 | Evenity, Prolia |
| Si-Bone, INC. | $194.72 | 2019-2023 | |
| Spr Therapeutics, INC | $138.65 | 2024-2025 | Sprint Pns System |
| Medtronic USA, INC. | $138.09 | 2019 | |
| Abbott Laboratories | $136.09 | 2019-2021 | |
| Vertex Pharmaceuticals Incorporated | $85.94 | 2024-2025 | |
| Averitas Pharma INC. | $61.03 | 2023 | Qutenza |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Radius Health, INC. | $36.09 | 2019-2025 | Tymlos |
| Stryker Corporation | $29.23 | 2019 | |
| Biodelivery Sciences International, INC. | $27.68 | 2021 | |
| Janssen Biotech, INC. | $26.93 | 2019 | |
| Novartis Pharmaceuticals Corporation | $22.27 | 2019 | |
| Relievant Medsystems, INC. | $21.98 | 2021 | |
| Nalu Medical, INC. | $21.39 | 2023 | Nalu Neurostimulation System |
| Spinal Simplicity, LLC | $18.06 | 2021 | |
| Travere Therapeutics, INC. | $17.73 | 2019 | |
| Endo Pharmaceuticals INC. | $16.09 | 2019 | |
| Painteq LLC | $15.41 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $13.70 | 2019 | |
| Epimed International, INC | $10.97 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ralph Menard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.